Found 11 resultsAuthor [ Title] Type Year
Filters: Author is Horowitz, M [Clear All Filters]
Autologous vs. Reduced Intensity Allogeneic Hematopoietic Cell Transplantation for Patients with Chemosensitive Follicular Non-Hodgkin's Lymphoma Beyond First Complete Response or First Partial Response. Biol Blood Marrow Transplant, 17, 1051-1057. presented at the 07/2011. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/21073974. (2011).
Blood and Marrow Transplant Clinical Trials Network Toxicity Committee Consensus Summary: Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant, 11, 571-575. presented at the 08/2005. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16041306. (2005).
Developing Materials for Transplant Centers to Share BMT CTN Clinical Trial Results with their Patients: A Pilot Study (Poster). In NCI ASCO Cancer Trials Accrual Symposium. presented at the 2010, Bethesda, MD. Retrieved from http://university.asco.org/CT2010. (2010).
Development of an Accrual Assessment Tool for BMT CTN Transplant Trials: A Proactive Approach. In NCI ASCO Cancer Trials Accrual Symposium Poster Session. presented at the 29/04/2010, Bethesda, MD. Retrieved from http://university.asco.org/CT2010. (2010).
Etanercept, Mycophenolate, Denileukin, or Pentostatin Plus Corticosteroids for Acute Graft-Versus-Host Disease: A Randomized Phase 2 Trial from the Blood and Marrow Transplant Clinical Trials Network. Blood, 114, 511-517. presented at the 07/2009. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/19443659. (2009).
Maximizing Accrual to Transplant Trials in Multiple Myeloma (MM): Lessons from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN), Eastern Cooperative Oncology Group (ECOG) and Cancer and Leukemia Group B (CALGB) Collaboration (Poster). In NCI ASCO Cancer Trials Accrual Symposium. presented at the 2010, Bethesda, MD.. (2010).
One-Unit Versus Two-Unit Cord-Blood Transplantation for Hematologic Cancers. N Engl J Med, 371, 1685-1694. presented at the 10/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25354103. (2014).
Peripheral-Blood Stem Cells Versus Bone Marrow from Unrelated Donors. N Engl J Med, 367, 1487-1496. presented at the 10/2012. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23075175. (2012).
A Phase II Study of Allogeneic Transplantation for Older Patients with AML in First Complete Remission Using a Reduced Intensity Conditioning Regimen: Results from CALGB 100103/BMT CTN 0502. In 54th Annual ASH Meeting. presented at the 08/12/2012, Atlanta, GA. Retrieved from http://www.hematology.org/Meetings/Annual-Meeting/. (2012).
Sirolimus Is Associated With Veno-Occlusive Disease of the Liver After Myeloablative Allogeneic Stem Cell Transplantation. Blood, 112, 4425-4431. presented at the 12/2008. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/18776081. (2008).
Use of Biological Assignment in Hematopoietic Stem Cell Transplantation Clinical Trials. Clin Trials, 5, 607-616. presented at the 12/2008. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/19029209. (2008).